Department of Ophthalmology, University Hospital Hairmyres, Glasgow, UK.
Ocul Immunol Inflamm. 2023 Apr;31(3):638-640. doi: 10.1080/09273948.2022.2042319. Epub 2022 Feb 28.
To report a case of posterior scleritis following COVID-19 vaccination.
Case report.
A 78-year-old female presented with headache and right-sided visual loss 10 days after the second dose of COVID-19 vaccine. 'Examination showed disc oedema and a serous retinal detachment. B-scan ultrasound showed thickening of the posterior sclera with retroscleral fluid. CT head with venogram excluded venous sinus thrombosis. The patient's condition improved rapidly with oral corticosteroids with restoration of vision and resolution of disc swelling and serous detachment by 4 weeks.
Posterior scleritis should be considered in patients presenting with headaches and blurred vision following vaccination. Timely diagnosis and treatment with corticosteroids can prevent permanent visual loss.
报告 1 例接种 COVID-19 疫苗后发生后巩膜炎。
病例报告。
一名 78 岁女性在接种 COVID-19 疫苗第二剂后 10 天出现头痛和右侧视力丧失。检查显示视盘水肿和浆液性视网膜脱离。B 型超声显示后巩膜增厚伴巩膜后积液。头颅 CT 加静脉造影排除了静脉窦血栓形成。患者的病情在口服皮质类固醇治疗后迅速改善，视力恢复，视盘肿胀和浆液性脱离在 4 周内消退。
接种疫苗后出现头痛和视力模糊的患者应考虑后巩膜炎。及时诊断和皮质类固醇治疗可以预防永久性视力丧失。
